According to NRC Health
's latest financial reports the company has $22.49 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | $25.02 M | -53.96% |
2021-12-31 | $54.36 M | 56.71% |
2020-12-31 | $34.69 M | 156.64% |
2019-12-31 | $13.51 M | 4.05% |
2018-12-31 | $12.99 M | -62.6% |
2017-12-31 | $34.73 M | 5.18% |
2016-12-31 | $33.02 M | -21.65% |
2015-12-31 | $42.14 M | 5.25% |
2014-12-31 | $40.04 M | 81.25% |
2013-12-31 | $22.09 M | 166.62% |
2012-12-31 | $8.28 M | 2.52% |
2011-12-31 | $8.08 M | 129.67% |
2010-12-31 | $3.51 M | 40.09% |
2009-12-31 | $2.51 M | 126.51% |
2008-12-31 | $1.1 M | -67.9% |
2007-12-31 | $3.45 M | 73.91% |
2006-12-31 | $1.98 M | -80.71% |
2005-12-31 | $10.29 M | -45.8% |
2004-12-31 | $18.99 M | 17.21% |
2003-12-31 | $16.2 M | 47.63% |
2002-12-31 | $10.97 M | 42.26% |
2001-12-31 | $7.71 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
![]() Nymox Pharmaceutical NYMX | $0.13 M | -99.41% | Bahamas |
![]() NRC Health
NRC | $22.49 M | 0.00% | ๐บ๐ธ USA |